Items

• 
  2022-06-08

  Moderna says updated Covid-19 vaccine booster shows stronger antibody response against Omicron

  This is a news story from CNN by Jamie Gumbrecht. Moderna believes that their COVID-19 booster is effective against Ominicron, and more effective compared to the normal two doses. The claim is that the booster provided a stronger antibody response than the initial two doses.
• 
  2022-04-06

  Get Your Kids Vaccinated

  This is an Instagram post by carlamaeperaltasalmoringfkfhdk. This picture shows a kid that just got their second dose of the Pfizer vaccine. The date says that the shot happened on April 6, 2022.
• 
  2022-04-07

  Get Vaccinated

  This is an Instagram post from myinnovage. This is a team that worked on getting people vaccinated. Here, one of the pictures that was chosen was of a woman holding a blank vaccine card and wearing a mask. This team is in Colorado and is encouraging people to get their booster shots.
• 
  2020-08-28

  A flier advertising free Covid-19 shots in Sacramento.

  This event offered Pfizer and Johnson and Johnson vaccines, free Uber rides and Spanish and Hmong interpreters. The event was sponsored by the NCNW Sacramento Valley Section and La Familia Counseling Center.
• 
  2021-03-30

  Vaccines Rollin’ Out. Covid’s Over?

  The picture that I have chosen for the archive is one of me after getting the vaccine in March of 2021. After receiving the vaccine, I captioned the photo, like many of my optimistic peers, “Covid over.” Since last February of 2020 when the pandemic started, a vaccine was finally being distributed across the country (USA), and a majority of people were ecstatic that quarantining was over. But little did I know, many people would be against taking the vaccine leading to variants of Covid-19 like the Delta variant. This picture was taken six months ago from when this archive was being made, and Covid is still not over because people choose to believe these conspiracy theories of the government putting microchips in the vaccine and other ridiculous things like that. Even with a vaccine that is available to everyone in the United States, the pandemic is still raging on with the Delta variant running rampant in the hospitals which has an even worse effect than the normal strain that was going around from February 2020 to around May of 2021. This picture is just to show how hopeful people get from new technology coming out that can save thousands of lives, but ignorant people choose to convince others what they believe since they are spreading their crazy selfish conspiracies. I was so hopeful of having a normal sophomore year of college, but once again Covid is still present (as of September 14, 2021) putting the elderly at risk and quarantining/putting a hold on people’s lives.
• 
  2021-06

  The never-ending covid testing

  There was an incoming case that started to disseminate from my hometown's airport and the adjacent subway line. I lived nearby the airport, so I was inside the "high-risk grid" of this incident. I received countless calls from the community center forcing me to do the covid testing, and I was also asked to do the test at a specific center far away from my home. The photo I'm sharing is taken at 10 pm traveling to the testing point after work. I had to line up for 3 hours in a burning summer night. It is definitely memorable.
• 
  2020-09-08

  Stay safe during COVID-19 pandemic: Get your flu shot now

  A press release from Banner Health encouraging people to get the flu shot to stay safer.
• 
  2021-04-16

  Vaccine Booster Shots

  This article is about the Moderna and Pfizer vaccine shots will likely require follow-up booster shots. The executives of both companies announced that it is likely that people that received the vaccine will need their first booster shot within 12 months of receiving the vaccine, then possibly yearly shots afterward. At the end of the article it does note that the Pfizer vaccine is still 93.1% effective 6 months after the vaccine and Moderna reports 90% effective after the 6 month period. However it still seems that we will have to receive booster shots, which is no big deal unless people have the side effects that they had from the original vaccine. This would absolutely prevent many people from following through or even receiving the original vaccine.
• 
  2020-04-06

  Johnson and Johnson Vaccine Diary-Day 1

  DAY 1: On 4/6/21, I received a single dose of the Johnson and Johnson/Janssen vaccine courtesy of my university. Although out of my control, I was determined to not experience side effects. I woke up somewhat late, so I only had time to eat half a Cliff bar on the way there. I did not drink that much water either. I finished my shot at 11:46am. I don't really mind needles, but I will say that the vaccine shot hurts very slightly more than the flu shot. I think the needle has to stay in for longer. Nevertheless, it was just a short pinch, not bad at all. The process was very quick. After my shot, I sat in the lobby, where I was instructed to wait 15 minutes just in case I had a bad reaction. After my fifteen minutes were up, I received my vaccination card. Although many people do, I chose not to post it on social media. I carried about my day as usual. It was only around 9:30pm when I finally started to feel the side effects. It was ironic because right after I told my friend I felt fine, I felt the aches. Throughout the night, my body felt sore and achy, like I worked out the day before. Stretching made it feel better. At 11:30pm, I was getting fever symptoms. I was extremely tired and had chills, despite being told that my skin felt very hot. I kept shivering despite being wrapped up in a blanket. While I was uncomfortable, the side effects were more of a mild inconvenience. If need be, I could've continued to carry on my day. But it was getting late and I had an early exam the next day, so I decided to snuggle up in a blanket and watch videos until I fell asleep.
• 
  2021-04-01

  News Article: ASU watching new COVID-19 'Arizona variant' with a mutation known to weaken vaccines

  By Amanda Morris of the Arizona Republic: Arizona State University researchers have found a home-grown variant of the coronavirus emerging in Arizona that they say should be monitored closely because it carries a mutation known for weakening vaccines. In a non-peer reviewed study that published Sunday, researchers said they have detected 17 cases of the new variant since February, 15 of which were in Arizona. The other two cases were found in Houston in late February and New Mexico in early March, suggesting that the variant has begun to spread. "My hope is that we do not see more of these cases. The whole point of surveillance is to keep this from spreading," said Dr. Efrem Lim, an ASU virologist and assistant professor. The variant is known as the B.1.243.1 variant, and descends from a common lineage of the virus called B.1.243, which nationally makes up about 2.5% of all cases, according to David Engelthaler, director of the Translational Genomics Research Institute's infectious disease division in Flagstaff. "It's not dominant. But, there's a fair amount of that lineage that has been able to hang around," Engelthaler said. "It seems to have picked up this E484K mutation, what we call the 'eek!'" This E484K mutation has also been seen in the variants first detected in South Africa and Brazil, as well as one new variant recently discovered in New York. Numerous studies have shown that this mutation — located in the spike of the virus — lowers antibody responses to the virus and could weaken vaccines. Antibodies are one of the body's tool to recognize and fight the virus. The E484K mutation has been shown to weaken antibody responses. One study from Seattle showed that it caused the neutralizing effects of antibodies to decrease by tenfold, and numerous other studies have shown similar results. American vaccine development company Novavax reported that its COVID-19 vaccine was 96.4% effective against the original coronavirus strain and 86.3% effective against the U.K. variant, but was far less effective in South Africa, where the South Africa variant carrying this mutation is dominant. In the South Africa trials, the vaccine was shown to be 48.6% effective overall, and 55.4% effective in HIV-negative individuals. Moderna announced a sixfold reduction in antibody responses from its vaccine against the South Africa variant, and Pfizer observed a drop in vaccine-induced antibody responses against the South Africa variant. The Johnson & Johnson vaccine is reported to be 64% effective against moderate to severe COVID-19 in trials in South Africa vs. 72% effective in U.S. trials. Though the E484K mutation appears to reduce antibody response and possibly reduce vaccine efficacy, Lim stressed that vaccines still work well and said people should get their vaccines as planned. Scientists are monitoring mutations in the spike of the novel coronavirus. Community spread is a concern Though the new Arizona variant carries this mutation, it's still possible for the variant to fizzle out and stop spreading. Lim said researchers have found two other cases where viruses within the B.1.243 lineage independently picked up the E484K mutation, but did not spread. "In both cases, they never led to more transmissions," Lim said. Engelthaler has also tracked other lineages where the E484K mutation showed up, but those strains fizzled out. Overall, researchers have detected over 60 samples containing the E484K mutation statewide, according to TGen's Arizona COVID-19 sequencing dashboard. In order to continue spread, Engelthaler said variants need to be very "fit." "This mutation has popped up on multiple instances and then just goes away," he said. "This one mutation by itself doesn't give the virus superpowers." "It’s definitely a mutation of concern but time will tell if it will be a variant of concern," he added. If the mutation shows up in a more fit version of the virus, then Engelthaler said it becomes more of a concern. The new variant in Arizona is different than past cases because it has already spread from one person to another and could spread further, according to Lim. He said "one-off" mutations here and there are normal, but that the bigger question is about the transmission levels of this variant. A variant's ability to spread to others is also dependent on human behavior, Lim said. If people follow public health guidelines, they are less likely to spread variants to others. In total, Lim said the new Arizona variant has 11 mutations, which is "quite a bit more" than normal virus variations. These 11 mutations could be helping the virus survive or spread and could also act as a "fingerprint" to help researchers identify the new variant, Lim said. Another one of the 11 mutations is located in the spike that the virus uses to attach to and infect cells. Engelthaler said that because of the importance of the spike, any mutations in that area could affect things like how fast the virus spreads or how severe the related illness is. Both Lim and Engelthaler said it's too soon to tell whether the other mutations in this variant have any effect. Overall, this variant still seems to account for a very low percentage of overall cases in the state, according to Dr. Joshua LaBaer, the executive director of ASU's Biodesign Institute. ASU researchers wrote that it's still possible there are more undetected cases of the variant since there are limited efforts to genetically monitor the virus nationwide. In Arizona, roughly 1.3% of cases overall have been genetically sequenced, or analyzed, according to TGen's Arizona COVID-19 sequencing dashboard. In February and March, over 3% of cases were sequenced, higher than national rates of sequencing, which were below 1% in January. ASU is working with the Arizona Department of Health Services to monitor the new variant and hopefully prevent further spread through contact tracing and other public health measures, Lim said. California and UK variant cases rise Currently the Arizona variant is only considered a "variant of interest" and not a "variant of concern." These are different categories outlined by the CDC and used to assess the risk level of each variant. The CDC defines "variants of interest" as those that are associated with potential changes, whereas "variants of concern" have evidence showing actual changes such as increased transmission, more severe disease or antibody evasion. There are five variants of concern, which include variants first identified in the United Kingdom, South Africa, Brazil and California. Two variants from California were elevated from variant of interest to variant of concern this month and have rapidly spread in Arizona. "They're closely related to each other and have definitely been documented with increased transmissibility and some impact on some antibody treatment," Engelthaler said. In November 2020, both the California variants accounted for only 0.73% of Arizona's genetically sequenced samples. By March, they accounted for 31.64% of samples and are predominant variants statewide. One non-peer reviewed study from the University of California San Francisco showed weaker antibody responses against the California variants. Because of concerns that monoclonal antibody treatments may be less effective against these two variants, the U.S. Department of Health and Human Services announced two weeks ago that it would limit the distribution of one treatment to states with high levels of the California variant, including Arizona. The California Department of Public Health also recommended that the state stop distributing the treatment, which is made by American pharmaceutical company Eli & Lily. In a health alert, the department said this treatment was unlikely to be active against the California variants. The U.K. variant, which is highly contagious, has also been spreading statewide ever since it was first detected in late January. In March the U.K. variant accounted for 4.72% of genetically analyzed samples. Currently, Engelthaler said Arizona has over 100 cases of the U.K. variant and over 1,000 cases of the California variants. Arizona also detected its first cases of the South Africa variant last week. So far, Lim said that all of the variants of concern are manageable and have not risen to the level of "variant of high consequence," which the CDC defines as variants that are shown to significantly reduce the effectiveness of prevention and medical measures. "The risk is whether one of these current variants of concern acquire additional mutations that push it up to the next level," Lim said. To prevent further mutations, LaBaer said it's important to prevent spread of the virus by continuing to follow health guidelines and getting vaccinated. The more the community can prevent the spread of the virus, the less mutations will occur, he said. "We're kind of in this race right now between the developed dominance of these much more infectious variants that are now spreading throughout the country and getting people vaccinated," LaBaer said. "At the moment, I'm a little worried that the spread of this virus is so fast that that may outpace our ability to get vaccines in arms." He said it was theoretically possible that new variants could escape the vaccines, meaning that the public would move backward away from reaching herd immunity. But Lim said the vaccines can easily be updated to protect against new variants. Pharmaceutical companies like Pfizer and Moderna are already working on developing updated booster shots. In the meantime, researchers will continue to monitor the Arizona variant to see if it spreads further. Engelthaler said he expects the most fit variants of the virus to become more dominant statewide as people continue to get vaccinated and stamp out less successful strains. "There's a bit of a race here with the virus — a survival of the fittest race," Engelthaler said. "But what we don't want is to raise too much concern that things are going in the wrong direction...what we're doing is closely watching the evolution of a virus like we never have before. It's good that we have this capability, it's more important to put it into context." Amanda Morris covers all things bioscience, which includes health care, technology, new research and the environment. Send her tips, story ideas, or dog memes at amorris@gannett.com and follow her on Twitter @amandamomorris for the latest bioscience updates. Independent coverage of bioscience in Arizona is supported by a grant from the Flinn Foundation.
• 
  2020-07-18

  Police in the U. S. killed three people per day in 2019, for a total of nearly 1,100 deaths

  Police in the U. S. killed three people per day in 2019, for a total of nearly 1,100 deaths. Those numbers are far higher than in other western countries. In England and Wales, three people were shot and killed by police last year. Roughly as many people were killed over the past decade in those countries as were killed by police in the U.S. in an average week (19). Despite the large number of police killings every year, police are almost never charged for excessive force. Between 2013 and 2019, 99% of killings resulted in no charges, according to Mapping Police Violence.
• 
  2021-01-04

  Dolal Idd Was Shot and Killed by Police

  Twenty-three year old Dolal Idd was shot and killed by police Wednesday evening outside a gas station less than a mile away from the site of George Floyd’s death. Dolal's family only learned of his death after police raided their home in the middle of the night. Minneapolis Police Chief Arradondo shared that officers were performing a traffic stop as part of a "probable cause” weapons investigation when they approached Idd. Arradondo refused to provide specifics. The edited body cam footage released by the police has only raised further questions about the incident. "We want police officers to have serious consequences for their use of force -- and right now they don't. Right now they’re given a great deal of discretion to kill people,” said Jaylani Hussein, Executive Director of CAIR (@cairmn).
• 
  02/07/2021

  Jo Ann Richey Oral History, 2021/02/07

  This is an interview with Jo Ann Richey about her COVID-19 vaccination experience in January of 2021. She talks about how pandemic restrictions have affected her work and social life. She also speaks about where and how her vaccine was conducted. She includes personal insight into how she hopes the vaccines may change her life and society as whole in the future. Contributed by Clinton P. Roberts, HSE, for Arizona State University for the #RuralVoices and #VaccineStories collections
• 
  2021-01-03

  Covid Shot

  its about the covid vaccine and how so many people worked on it
• 2021-01-18

  My experience with getting the Covid vaccine

  For 24 hours I felt something weird on my arm but the doctor told me to move it around so I can get into my body. The area of the shot felt sore, just like any other vaccine. After a week it barely felt like anything. It just felt like any other vaccine.